Company Filing History:

4 out of 52

Denali Therapeutics Inc.

patents

Years Active: 2021-2024

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12129263 - Kinase inhibitors and uses thereof (2024-10-29),

2. 11851440 - Modulators of eukaryotic initiation factor 2B, compositions and methods (2023-12-26),

3. 11236100 - Modulators of eukaryotic initiation factor 2B, compositions and methods (2022-02-01),

4. 11203600 - Kinase inhibitors and uses thereof (2021-12-21),

Title: The Innovative Journey of Christopher R H Hale

Introduction: Christopher R H Hale is a distinguished inventor based in South San Francisco, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Christopher R H Hale's latest patents include cutting-edge technologies in the healthcare sector, revolutionizing the way medical treatments are administered.

Career Highlights: With a career spanning over two decades, Christopher R H Hale has established himself as a visionary inventor, with numerous patents that have significantly impacted industries such as biotechnology and electronics.

Collaborations: Throughout his career, Christopher R H Hale has collaborated with leading research institutions and universities to further develop his innovative ideas and bring them to fruition.

Conclusion: Christopher R H Hale's relentless pursuit of innovation and his passion for creating solutions to complex problems have solidified his reputation as a pioneering inventor in the modern era.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com